Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
-
- 高橋 俊二
- 公益財団法人がん研究会
書誌事項
- タイトル
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.
- 著者
- Yoshinori Ito, Koichi Nagasaki, Yoshio Miki, Takuj Iwase, Futoshi Akiyama, Masaaki Matsuura, Rie Horii, Masujiro Makita, Nahomi Tokudome, Masaru Ushijima, Masataka Yoshimoto, Shunji Takahashi, Tetsuo Noda, Kiyohiko Hatake.
収録刊行物
-
- Cancer Sci.
-
Cancer Sci. 120 130-136, 2010
- Tweet
詳細情報
-
- CRID
- 1010000782115821325
-
- 資料種別
- journal article
-
- データソース種別
-
- KAKEN